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Mentor: Alexandra Gutierrez
E-cigarettes represent a popular method of nicotine replacement and an adjuvant tool to 
aid in smoking cessation; however, the effect on disease course and smoking cessation 
efficacy in inflammatory bowel disease (IBD) patients is unclear. The primary aim of this 
project was to delineate the behavior and pattern of e-cigarette usage in IBD patients. 
All patients with an IBD diagnosis and self-reported history of e-cigarette use were 
retrospectively identified from a prospective cohort of IBD patients recruited between 
2014 and 2016. Eligible patients who consented to participate were administered a 
comprehensive telephone questionnaire addressing multiple e-cigarette behaviors 
including the type and quantity of e-cigarettes used, duration of use, nicotine content, 
and motivations for use. Kruskal-Wallis and Fisher’s exact tests were used to evaluate 
comparative data, as appropriate. Of 304 patients screened, 49 (16.1%) were eligible for 
study inclusion. Of those eligible, 27 consented to participate, 14 declined to participate, 
7 were unable to be contacted, and 1 yielded insufficient data. Seven (25.9%) were 
current e-cigarette users and 20 (74.1%) were prior users. Current users were less likely 
to be current smokers (0% vs 50%, p = 0.026) and used e-cigarettes for a longer duration 
of time (34 vs 6 months, p = 0.036). Use of e-cigarettes reduced cravings for regular 
cigarettes in 21 (77.8%) people with sustained smoking cessation in 17 (63%). Motivation 
for choosing e-cigarettes over other methods of smoking cessation included poor success 
of other methods (74%) as well as the appeal of the hand to mouth habit and resemblance 
to regular cigarettes (64%). IBD patients who used e-cigarettes experienced a reduced 
craving for regular cigarettes with a smaller but substantial proportion experiencing 
sustained smoking remission. Larger scale studies are needed to confirm the efficacy of 
e-cigarettes in smoking cessation among IBD patients as well as determine the impact 
on clinical course.
